Mundipharma Pharmaceuticals S.L.赞助的临床试验
总计79个结果
-
Mundipharma Pharmaceuticals S.L.Alpha Bioresearch S.L.; Dynamic Solutions撤销
-
Mundipharma Pharmaceuticals srlBioikos Ambiente Srl完全的
-
Mundipharma Pharmaceuticals B.V.完全的
-
Mundipharma Pharmaceuticals Sdn. Bhd.完全的
-
Mundipharma (China) Pharmaceutical Co. Ltd完全的
-
Mundipharma (China) Pharmaceutical Co. Ltd完全的
-
Mundipharma (China) Pharmaceutical Co. Ltd完全的
-
Mundipharma (China) Pharmaceutical Co. Ltd未知
-
Mundipharma Pharmaceuticals S.L.Spanish Clinical Research Network - SCReN; Spanish Society for Emergency Medicine (SEMES)完全的
-
PETHEMA FoundationJanssen-Cilag Ltd.; Mundipharma Pharmaceuticals B.V.完全的
-
Amyndas Pharmaceuticals S.A.未知SARS-CoV-2 感染引起的急性呼吸窘迫综合征(重症 COVID19)
-
PETHEMA FoundationMillennium Pharmaceuticals, Inc.; Dynamic Science S.L.主动,不招人
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.完全的
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.完全的
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.撤销
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.完全的
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.完全的
-
Glenmark Pharmaceuticals Ltd. IndiaGlenmark Pharmaceuticals S.A.完全的
-
Kyowa Kirin Pharmaceutical Development LtdApices Soluciones S.L.完全的
-
Vanda PharmaceuticalsCross Research S.A.完全的
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.完全的
-
Oncology Specialists, S.C.Millennium Pharmaceuticals, Inc.终止